Effect of oophorectomy on circulating testosterone and androstenedione levels in patients with endometrial cancer.
D000230:Adenocarcinoma / Q000097:blood* / Q000188:drug therapy; D000328:Adult; D000368:Aged; D000735:Androstenedione / Q000097:blood*; D002369:Castration; D003475:Curettage; D004967:Estrogens / Q000494:pharmacology / Q000627:therapeutic use; D005187:Fallopian Tubes / Q000601:surgery; D005260:Female; D006801:Humans; D007044:Hysterectomy; D008525:Medroxyprogesterone / Q000494:pharmacology / Q000627:therapeutic use; D008593:Menopause; D008657:Metabolic Clearance Rate / Q000187:drug effects; D008875:Middle Aged; D010053:Ovary / Q000378:metabolism; D011863:Radioimmunoassay; D013739:Testosterone / Q000097:blood*; D014594:Uterine Neoplasms / Q000097:blood* / Q000188:drug therapy
D004967:Estrogens; D013739:Testosterone; D000735:Androstenedione; D008525:Medroxyprogesterone